{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:25:04Z","timestamp":1788279904044,"version":"build-2803163510"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ejphar.2026.179241","type":"journal-article","created":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:59:17Z","timestamp":1786978757000},"page":"179241","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Morin, a bioflavonoid from a traditional medicinal plant, attenuates inflammasome-associated neuroinflammation in drug-resistant epilepsy"],"prefix":"10.1016","volume":"1032","author":[{"given":"Nidhi","family":"Khedpande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4166-3380","authenticated-orcid":false,"given":"Kalyani","family":"Barve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2026.179241_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175213","article-title":"Morin offsets PTZ-induced neuronal degeneration and cognitive decrements in rats: the modulation of TNF-\u03b1\/TNFR-1\/RIPK1,3\/MLKL\/PGAM5\/Drp-1, IL-6\/JAK2\/STAT3\/GFAP and Keap-1\/Nrf-2\/HO-1 trajectories","volume":"931","author":"Abd El-Aal","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"9\u201310","key":"10.1016\/j.ejphar.2026.179241_bib2","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/08830738241273339","article-title":"Evaluation of GFAP, S100B, and UCHL-1 levels in children with refractory epilepsy","volume":"39","author":"Aksoy","year":"2024","journal-title":"J. Child Neurol."},{"key":"10.1016\/j.ejphar.2026.179241_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2856063","article-title":"Mangiferin and Morin attenuate oxidative stress, mitochondrial dysfunction, and neurocytotoxicity, induced by amyloid beta oligomers","volume":"2018","author":"Alberdi","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179241_bib4","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1007\/s10571-022-01250-3","article-title":"Role of pyroptosis, a pro-inflammatory programmed cell death, in epilepsy","volume":"43","author":"Atabaki","year":"2023","journal-title":"Cell. Mol. Neurobiol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179241_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/brainsci11050663","article-title":"Mechanisms of drug resistance in the pathogenesis of epilepsy: role of neuroinflammation. a literature review","volume":"11","author":"Bazhanova","year":"2021","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2026.179241_bib6","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.neuroscience.2024.03.029","article-title":"Mechanism of NLRP3 inflammasome in epilepsy and related therapeutic agents","volume":"546","author":"Chen","year":"2024","journal-title":"Neuroscience"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179241_bib7","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1111\/epi.17090","article-title":"OV329, a novel highly potent \u03b3\u2010aminobutyric acid aminotransferase inactivator, induces pronounced anticonvulsant effects in the pentylenetetrazole seizure threshold test and in amygdala\u2010kindled rats","volume":"62","author":"Feja","year":"2021","journal-title":"Epilepsia"},{"key":"10.1016\/j.ejphar.2026.179241_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.foodres.2017.10.010","article-title":"Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: an in vitro evaluation with focus on antiepileptic drugs","volume":"103","author":"Ferreira","year":"2018","journal-title":"Food Res. Int."},{"key":"10.1016\/j.ejphar.2026.179241_bib9","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.46414","article-title":"Vigabatrin (Sabril) for the treatment of refractory complex focal seizures in adults: pharmacologic and clinical considerations","author":"Gatson","year":"2023","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179241_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0974-8490.129046","article-title":"Anticonvulsant activity of Morus alba and its effect on brain gamma-aminobutyric acid level in rats","volume":"6","author":"Gupta","year":"2014","journal-title":"Pharmacogn. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib10","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.biomag.2013.10.005","article-title":"Anticonvulsant activity of Morusin isolated from Morus alba: modulation of GABA receptor","volume":"4","author":"Gupta","year":"2014","journal-title":"Biomedicine & Aging Pathology"},{"issue":"2","key":"10.1016\/j.ejphar.2026.179241_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.4103\/0974-8490.129046","article-title":"Anticonvulsant activity of Morus alba and its effect on brain gamma-aminobutyric acid level in rats","volume":"6","author":"Gupta","year":"2014","journal-title":"Pharmacogn. Res."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179241_bib13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1476-5381.2011.01228.x","article-title":"Flavonoid modulation of GABA(A) receptors","volume":"163","author":"Hanrahan","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179241_bib14","doi-asserted-by":"crossref","first-page":"363","DOI":"10.33549\/physiolres.930209","article-title":"Does vigabatrin possess an anticonvulsant action against pentylenetetrazol-induced seizures in developing rats?","volume":"51","author":"Haugvicov\u00e1","year":"2002","journal-title":"Physiol. Res."},{"key":"10.1016\/j.ejphar.2026.179241_bib15","article-title":"Natural medicines for the treatment of epilepsy: bioactive components","author":"He","year":"2021","journal-title":"Pharmacology and Mechanism"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179241_bib16","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1007\/s00702-006-0482-x","article-title":"Time dependent alterations of co-localization of S100\u03b2 and GFAP in the MPTP-treated mice","volume":"113","author":"Himeda","year":"2006","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179241_bib17","doi-asserted-by":"crossref","first-page":"686","DOI":"10.3390\/biomedicines11030686","article-title":"The roles of glutamate receptors and their antagonists in status epilepticus, refractory status epilepticus, and super-refractory status epilepticus","volume":"11","author":"Huang","year":"2023","journal-title":"Biomedicines"},{"issue":"7","key":"10.1016\/j.ejphar.2026.179241_bib18","doi-asserted-by":"crossref","first-page":"352","DOI":"10.4103\/2221-1691.237078","article-title":"Anti-epileptic effect of morin against experimental pentylenetetrazol-induced seizures via modulating brain monoamines and oxidative stress","volume":"8","author":"Kandhare","year":"2018","journal-title":"Asian Pac. J. Trop. Biomed."},{"key":"10.1016\/j.ejphar.2026.179241_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107458","article-title":"Attenuation of mitochondrial refractory epilepsy in rotenone corneal kindling model of drug resistance by idebenone: an approach to bypass mitochondrial complex I","volume":"207","author":"Kaur","year":"2024","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib20","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-70214-8","article-title":"Morin protects the blood-brain barrier integrity against cerebral ischemia reperfusion through anti-inflammatory actions in rats","volume":"10","author":"Khamchai","year":"2020","journal-title":"Sci. Rep."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179241_bib21","doi-asserted-by":"crossref","first-page":"16951","DOI":"10.1007\/s00210-025-04468-2","article-title":"Mitochondrial dysfunction and NLRP3 inflammasome activation in drug-resistant epilepsy: emerging insights and mitochondrial-targeted therapeutic strategies","volume":"398","author":"Khedpande","year":"2025","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"issue":"8","key":"10.1016\/j.ejphar.2026.179241_bib22","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1007\/s10571-009-9412-4","article-title":"Alterations of glial cells in the mouse hippocampus during postnatal development","volume":"29","author":"Kimoto","year":"2009","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179241_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2022.105754","article-title":"Bioinformatics guided rotenone adjuvant kindling in mice as a new animal model of drug-resistant epilepsy","volume":"147","author":"Kumar","year":"2022","journal-title":"Comput. Biol. Med."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179241_bib24","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/advances\/nmz047","article-title":"Perspective: therapeutic potential of flavonoids as alternative medicines in epilepsy","volume":"10","author":"Kwon","year":"2019","journal-title":"Adv. Nutr."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179241_bib25","doi-asserted-by":"crossref","first-page":"226","DOI":"10.5607\/en.2018.27.3.226","article-title":"Morin prevents granule cell dispersion and neurotoxicity via suppression of mTORC1 in a kainic acid-induced seizure model","volume":"27","author":"Lee","year":"2018","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.ejphar.2026.179241_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.eplepsyres.2024.107338","article-title":"Expression and correlation of the NOD-like receptor family, pyrin domain-containing 3 inflammasome and the silent information regulator 1 in patients with drug-resistant epilepsy","volume":"201","author":"Li","year":"2024","journal-title":"Epilepsy Res."},{"issue":"Dec","key":"10.1016\/j.ejphar.2026.179241_bib26","article-title":"Neuroinflammation in epileptogenesis: from pathophysiology to therapeutic strategies","volume":"14","author":"Li","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179241_bib28","series-title":"Models of Seizures and Epilepsy","first-page":"743","article-title":"Animal models of drug-refractory epilepsy","author":"L\u00f6scher","year":"2017"},{"issue":"9","key":"10.1016\/j.ejphar.2026.179241_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/cells12091233","article-title":"Animal models of drug-resistant epilepsy as tools for deciphering the cellular and molecular mechanisms of pharmacoresistance and discovering more effective treatments","volume":"12","author":"L\u00f6scher","year":"2023","journal-title":"Cells"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179241_bib30","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/14728222.2022.2039120","article-title":"Emerging therapeutic targets for epilepsy: preclinical insights","volume":"26","author":"\u0141ukawski","year":"2022","journal-title":"Expert Opin. Ther. Targets"},{"issue":"1-s","key":"10.1016\/j.ejphar.2026.179241_bib31","doi-asserted-by":"crossref","first-page":"105","DOI":"10.22270\/jddt.v10i1-s.3921","article-title":"Bradford assay as a high-throughput bioanalytical screening method for conforming pathophysiological state of the animal","volume":"10","author":"Mehata","year":"2020","journal-title":"J. Drug Deliv. Therapeut."},{"key":"10.1016\/j.ejphar.2026.179241_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.174506","article-title":"Morin attenuates memory deficits in a rat model of Alzheimer's disease by ameliorating oxidative stress and neuroinflammation","volume":"910","author":"Mohammadi","year":"2021","journal-title":"Eur. J. Pharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3390\/metabo13010083","article-title":"Biomarkers of drug resistance in temporal lobe Epilepsy in adults","volume":"13","author":"Panina","year":"2023","journal-title":"Metabolites"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib35","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0920-1211(98)00074-6","article-title":"Effects of vigabatrin treatment on status epilepticus-induced neuronal damage and mossy fiber sprouting in the rat hippocampus","volume":"33","author":"Pitk\u00e4nen","year":"1999","journal-title":"Epilepsy Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0920-1211(95)00093-3","article-title":"Vigabatrin and carbamazepine have different efficacies in the prevention of status epilepticus induced neuronal damage in the hippocampus and amygdala","volume":"24","author":"Pitk\u00e4nen","year":"1996","journal-title":"Epilepsy Res."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179241_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0271995","article-title":"Characterisation of NLRP3 pathway-related neuroinflammation in temporal lobe epilepsy","volume":"17","author":"Pohlentz","year":"2022","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179241_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.2174\/0118746098369369250119112935","article-title":"Recent advances in bioactive flavonoids-based nanotherapeutics as promising neuroprotectants in epilepsy","volume":"18","author":"Pradhan","year":"2025","journal-title":"Curr. Aging Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.3390\/brainsci13010102","article-title":"A comprehensive review on anti-inflammatory response of flavonoids in experimentally-induced epileptic seizures","volume":"13","author":"Rabidas","year":"2023","journal-title":"Brain Sci."},{"key":"10.1016\/j.ejphar.2026.179241_bib39","article-title":"The possible role of neurogenesis activators in temporal lobe epilepsy: state of art and future perspective","volume":"998","author":"salem Al-Dhahi","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"47","key":"10.1016\/j.ejphar.2026.179241_bib40","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202509668","article-title":"Refractory status epilepticus and therapeutic uncertainties: a comprehensive review on targeting neuroinflammation and rationale for developing a platform trial","volume":"12","author":"Samarasekera","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.ejphar.2026.179241_bib41","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.seizure.2021.06.028","article-title":"Brain concentrations of glutamate and GABA in human epilepsy: a review","volume":"91","author":"Sarlo","year":"2021","journal-title":"Seizure"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179241_bib42","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1017\/S1431927622012107","article-title":"Betahistine Attenuates seizures, neurodegeneration, apoptosis, and gliosis in the cerebral Cortex and Hippocampus in a mouse model of epilepsy: a histological, immunohistochemical, and biochemical Study","volume":"28","author":"Shalaby","year":"2022","journal-title":"Microsc. Microanal."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179241_bib43","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1007\/s12264-025-01348-w","article-title":"The role of neuroinflammation and network anomalies in drug-resistant epilepsy","volume":"41","author":"Shi","year":"2025","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.ejphar.2026.179241_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.yexmp.2025.105014","article-title":"Seizure susceptibility relates to microglial TREM2 expression and morphology in a multiple repeated low-dose kainic acid model","volume":"145","author":"Shin","year":"2026","journal-title":"Exp. Mol. Pathol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib45","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.55522\/jmpas.V11I1.2175","article-title":"Flavonoids and antiepileptic drugs: a comprehensive review on their neuroprotective potentials","volume":"11","author":"Shrivastava","year":"2022","journal-title":"Journal of Medical Pharmaceutical and Allied Sciences"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib46","doi-asserted-by":"crossref","first-page":"10","DOI":"10.53365\/nrfhh\/192949","article-title":"G., \u201cAnti-Epileptic Indian Medicinal Plants: a Comprehensive Review on their Ethnopharmacological Perspectives of Recent Advancement,\u201d","volume":"5","author":"Sinoriya","year":"2024","journal-title":"Natural Resources for Human Health"},{"key":"10.1016\/j.ejphar.2026.179241_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.yebeh.2015.05.039","article-title":"Ayurveda and botanical drugs for epilepsy: current evidence and future prospects","volume":"52","author":"Sriranjini","year":"2015","journal-title":"Epilepsy Behav."},{"issue":"17","key":"10.1016\/j.ejphar.2026.179241_bib48","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1212\/WNL.0000000000011839","article-title":"Incidence and prevalence of drug-resistant epilepsy","volume":"96","author":"Sultana","year":"2021","journal-title":"Neurology"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179241_bib49","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s00702-007-0790-9","article-title":"Damage to oligodendrocytes in the striatum after MPTP neurotoxicity in mice","volume":"114","author":"Takagi","year":"2007","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.ejphar.2026.179241_bib50","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.yebeh.2019.02.029","article-title":"PTZ-induced seizures in mice require a revised Racine scale","volume":"95","author":"Van Erum","year":"2019","journal-title":"Epilepsy Behav."},{"key":"10.1016\/j.ejphar.2026.179241_bib51","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2147\/NDT.S5236","article-title":"Treatment of refractory complex partial seizures: role of vigabatrin","author":"Waterhouse","year":"2009","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"45","key":"10.1016\/j.ejphar.2026.179241_bib52","doi-asserted-by":"crossref","first-page":"27425","DOI":"10.1074\/jbc.M115.667063","article-title":"Rotenone-induced impairment of mitochondrial electron transport chain confers a selective priming signal for NLRP3 inflammasome activation","volume":"290","author":"Won","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"Feb","key":"10.1016\/j.ejphar.2026.179241_bib53","article-title":"The role of NLRP3 and IL-1\u03b2 in refractory epilepsy brain injury","volume":"10","author":"Wu","year":"2020","journal-title":"Front. Neurol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179241_bib54","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1007\/s10753-020-01208-x","article-title":"Morin protects LPS-induced mastitis via inhibiting NLRP3 inflammasome and NF-\u03baB signaling pathways","volume":"43","author":"Yu","year":"2020","journal-title":"Inflammation"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179241_bib55","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12967-023-04802-3","article-title":"Impact of NQO1 dysregulation in CNS disorders","volume":"22","author":"Yuhan","year":"2024","journal-title":"J. Transl. Med."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179241_bib57","article-title":"Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of Tuberous sclerosis complex","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejphar.2026.179241_bib56","first-page":"1","article-title":"Flavonoid Myricetin modulates G A B A A receptor activity through activation of Ca 2+ channels and CaMK-II pathway","volume":"2012","author":"Zhang","year":"2012","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"2\u20133","key":"10.1016\/j.ejphar.2026.179241_bib58","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.eplepsyres.2006.05.017","article-title":"Effects of interleukin-1\u03b2 on hippocampal glutamate and GABA releases associated with Ca2+-induced Ca2+ releasing systems","volume":"71","author":"Zhu","year":"2006","journal-title":"Epilepsy Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926007235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T16:02:14Z","timestamp":1788278534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926007235"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":58,"alternative-id":["S0014299926007235"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179241","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Morin, a bioflavonoid from a traditional medicinal plant, attenuates inflammasome-associated neuroinflammation in drug-resistant epilepsy","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179241","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"179241"}}